Thieme E-Books & E-Journals -
Back
Thromb Haemost 2013; 109(02): 347-355
DOI: 10.1160/TH12-06-0378
New Technologies, Diagnostic Tools and Drugs
Schattauer GmbH

Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: Insights from the switching anti-platelet (SWAP) study

Jorge F. Saucedo
1   University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
,
Dominick J. Angiolillo
2   University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA
,
Roger DeRaad
3   Black Hills Clinical Research Center, Rapid City, South Dakota, USA
,
Andrew L. Frelinger III
4   Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA
,
Paul A. Gurbel
5   Sinai Center for Thrombosis Research, Baltimore, Maryland, USA
,
Timothy M. Costigan
6   Eli Lilly and Company or a subsidiary, Indianapolis, Indiana, USA
,
Joseph A. Jakubowski
6   Eli Lilly and Company or a subsidiary, Indianapolis, Indiana, USA
,
Clement K. Ojeh
6   Eli Lilly and Company or a subsidiary, Indianapolis, Indiana, USA
,
Suman Duvvuru
6   Eli Lilly and Company or a subsidiary, Indianapolis, Indiana, USA
,
Mark B. Effron
6   Eli Lilly and Company or a subsidiary, Indianapolis, Indiana, USA
,
for the SWAP Investigators › Author Affiliations